Lantern Pharma Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | – | +108.2% | +99.6% | +49.1% | +45.0% | +18.2% | 0.0% | |
| – | -36.6% | +912.4% | -19.3% | +23.5% | -10.1% | -31.3% | -11.2% | |
| – | -36.6% | +912.4% | -2.3% | +49.3% | – | – | – | |
| – | -33.5% | -619.2% | – | -202.0% | – | +314.1% | -71.5% | |
| – | +0.0% | +182.3% | -4.0% | +79.7% | -32.7% | -32.8% | -86.4% | |
| – | -207.1% | +182.3% | +120,929.8% | – | -618.9% | – | +228.2% | |
| – | – | +800.6% | -103.6% | +164.2% | -79.9% | – | – | |
| – | +0.0% | +0.0% | -100.0% | – | – | – | – | |
| – | +445.9% | +710.3% | +168.0% | -103.4% | -77.1% | – | +2,145.9% | |
| – | – | +2,187.2% | +85.0% | -144.4% | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.